Efficacy refers to how well a treatment, intervention, or device works under ideal, controlled conditions. In medical research, efficacy is typically measured in clinical trials where patient populations, dosing, and follow-up are carefully standardised. It is distinct from effectiveness, which describes how well a treatment works in real-world clinical practice, where patients are more varied, adherence is imperfect, and conditions are less controlled.
In the context of cardiac care and sudden cardiac arrest prevention, efficacy is a key concept when evaluating treatments. For example, the efficacy of ICD therapy in preventing sudden death is established through large randomised controlled trials. The efficacy of catheter ablation for ventricular tachycardia is measured by the proportion of patients who achieve freedom from recurrent arrhythmia under trial conditions.
ICD shock efficacy refers to the ability of a single shock to terminate ventricular fibrillation or VT (usually defined as successful termination in at least 70% of episodes at the programmed energy level, assessed at implant via defibrillation threshold testing). Modern ICDs have very high shock efficacy.
Understanding efficacy helps patients and clinicians make informed decisions about treatment options, weighing the proven benefit of an intervention against its risks and burden. It also underpins NICE guidance and clinical guidelines, which base recommendations on the strength and consistency of efficacy evidence from trials.
« Back to Glossary Index